Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety of Sildenafil in Premature Infants

ClinicalTrials.gov ID: NCT03142568

Public ClinicalTrials.gov record NCT03142568. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 5:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety of Sildenafil in Premature Infants at Risk of Bronchopulmonary Dysplasia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Describe the safety of sildenafil in premature infants at risk of bronchopulmonary dysplasia and determine preliminary effectiveness and pharmacokinetics (PK) of sildenafil. Funding Source - FDA Office of Orphan Products Development (OOPD).

Study identification

NCT ID
NCT03142568
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
109 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
7 Days to 28 Days
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2, 2018 (Actual)
Primary completion
Mar 1, 2025 (Actual)
Completion
Mar 1, 2025 (Actual)
Last update posted
Mar 30, 2026

2018 – 2025

United States locations

U.S. sites
14
U.S. states
12
U.S. cities
13
Facility City State ZIP Site status
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
University of Florida College of Medicine Jacksonville-Wolfson Children's Hospital Jacksonville Florida 32209 —
University of Florida Jacksonville Shands Medical Center Jacksonville Florida 32209 —
University of Illinois at Chicago Chicago Illinois 60612 —
Wesley Medical Center Wichita Kansas 67214 —
University of Kentucky Lexington Kentucky 40356 —
Ochsner Baptist Medical Center New Orleans Louisiana 70115 —
University of Mississippi Medical Center Jackson Mississippi 39216 —
Children's Hospital of Nevada at UMC Las Vegas Nevada 89106 —
Monmouth Medical Center Long Branch New Jersey 07740 —
Cohen Children's Medical Center of NY New Hyde Park New York 11040 —
Golisano Children's Hospital - University of Rochester Medical Center Rochester New York 14642 —
WakeMed Health and Hospitals Raleigh North Carolina 27610 —
University of Oklahoma Oklahoma City Oklahoma 73104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03142568, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 30, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03142568 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →